Bipolar Mixed States: An International Society for Bipolar Disorders Task Force Report of Symptom Structure, Course of Illness, and Diagnosis
Publication: American Journal of Psychiatry
Abstract
Objective
Episodes of bipolar disorder are defined as depressive or manic, but depressive and manic symptoms can combine in the same episode. Coexistence or rapid alternation of depressive and manic symptoms in the same episode may indicate a more severe form of bipolar disorder and may pose diagnostic and treatment challenges. However, definitions of mixed states, especially those with prominent depression, are not well established.
Method
The authors performed literature searches for bipolar disorder, multivariate analyses, and the appearance of the terms “mixed” in any field; references selected from the articles found after the search were combined after a series of conferences among the authors.
Results
The authors reviewed the evolution of the concept of mixed states and examined the symptom structure of mixed states studied as predominantly manic, predominantly depressive, and across both manic and depressive episodes, showing essentially parallel structures of mixed states based on manic or depressive episodes. The authors analyzed the relationships between mixed states and a severely recurrent course of illness in bipolar disorder, with early onset and increased co-occurring anxiety-, stress-, and substance-related disorders, and they used this information to derive proposed diagnostic criteria for research or clinical use.
Conclusions
The definitions and properties of mixed states have generated controversy, but the stability of their characteristics over a range of clinical definitions and diagnostic methods shows that the concept of mixed states is robust. Distinct characteristics related to the course of illness emerge at relatively modest opposite polarity symptom levels in depressive or manic episodes.
Formats available
You can view the full content in the following formats:
Information & Authors
Information
Published In
History
Received: 4 March 2012
Revision received: 29 April 2012
Accepted: 10 May 2012
Published online: 1 January 2013
Published in print: January 2013
Authors
Funding Information
Dr. Swann is a consultant for Merck; is a speaker for Abbott Laboratories, AstraZeneca, Merck, and Sanofi-Aventis; and is on data safety and monitoring boards for Cephalon and Pfizer. Prof. Perugi has received consulting fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, and Sanofi-Aventis; has received research support from AstraZeneca, Boehringer Ingheleim, Eli Lilly, GlaxoSmith Kline; is on the speakers/advisory boards of AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Jannsen-Cilag, Lundbeck, Pfizer, Sanofi Aventis, and Wyeth. Dr. Frye receives grant support from the Mayo Foundation, Myriad, NARSAD, NIMH, National Institute of Alcohol Abuse and Alcoholism, and Pfizer. Dr. Bauer receives advisory board fees from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Jannssen-Cilag, Lundbeck, Otsuka, and Servier and receives honoraria from AstraZeneca, Eli Lilly, Servier, Lundbeck, Bristol-Myers Squibb, Otsuka, Pfizer, and GlaxoSmithKline. Dr. Scott is supported by Fondation FondaMental and has received funding from the Medical Research Council UK BP II Cohort Study, NHS UK Research for Patient Benefit, NHS UK Service Delivery and Organization Program, NTW FSF Research Fund, and the Jansen-Cilag Unrestricted Educational Grant; she has received conference travel funding, speaking fees, or advisory board fees from AstraZeneca, Bristol-Myers Squibb-Otsuka, Eli Lilly, GlaxoSmithKline, Jansen-Cilag, Lundbeck, Sanofi-Aventis, and Servier. Dr. Ha has received research support from AstraZeneca, Eli Lilly, Otsuka, and Pfizer and has received honoraria from AstraZeneca, GlaxoSmithKline, Otsuka, and Pfizer. Dr. Suppes has received funding or medications for clinical grants from AstraZeneca, NIMH, Pfizer, and Sunovion Pharmaceuticals and has received royalties from Jones and Bartlett (formerly Compact Clinicals). Dr. Lafer and Dr. Bahk report no financial relationships with commercial interests.
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
Get Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).